{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:23:35Z","timestamp":1793669015121,"version":"4.5.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli studi \"Magna Graecia\" di Catanzaro"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Carbapenem-resistant <jats:italic>Acinetobacter baumannii<\/jats:italic> (CRAB) infections are associated with high morbidity and mortality rates. Furthermore, the role of CRAB respiratory colonization, including multisite colonization, has not yet been adequately highlighted in critically ill patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>In this retrospective multicenter study, conducted in 4 different Italian hospitals, patients with CRAB respiratory colonization +\/- other site who developed or did not develop clinically significant pneumonia from December 2015 to December 2023 were enrolled. The primary objective of the study was to identify risk factors associated with the development of pneumonia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>760 patients were enrolled; among them, 392 (51.5%) developed pneumonia, while 304 (39.9%) patients presented multisite colonization. Overall, in-hospital mortality was 76.3% with a higher mortality (79.6%) in patients who developed pneumonia (<jats:italic>p<\/jats:italic>\u2009=\u20090.033). In logistic regression analysis, factors associated with the development of pneumonia included: age, immunosuppressive therapy, COPD, ventilatory support and multisite colonization. A score was developed with AUC 0.72, CI95% 0.68\u20130.75, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and a sensitivity of 79% and specificity of 55% with a score\u2009&gt;\u20092 and a maximum score of 10 points. Multisite colonization was recorded more frequently in patients who developed pneumonia (51%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Finally, Kaplan-Meier curves showed a significantly reduced survival at 30 days (<jats:italic>p<\/jats:italic>\u2009=\u20090.005) and throughout the hospital stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.002) in patients with multisite colonization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study highlights the risk factors associated with the development of pneumonia in patients already colonized by CRAB. Multisite colonization showed an important role as a risk factor for the development of pneumonia and for its correlation with mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>Not applicable.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s10096-025-05137-1","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T09:48:11Z","timestamp":1745833691000},"page":"1667-1676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study"],"prefix":"10.1007","volume":"44","author":[{"given":"Alessandro","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Serapide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Alessandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Palma","family":"Gull\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Longhini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Quirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Morena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Marascio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Matera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"d\u2019Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Zullino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Maria","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Maria","family":"Trecarichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"5137_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s40121-022-00597-w","volume":"11","author":"C Bartal","year":"2022","unstructured":"Bartal C, Rolston KV, Nesher L (2022) Carbapenem-resistant Acinetobacter baumannii: colonization, infection, and current treatment options. Infect Dis Ther 11:683\u2013694. https:\/\/doi.org\/10.1007\/s40121-022-00597-w","journal-title":"Infect Dis Ther"},{"key":"5137_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eimc.2015.12.013","volume":"35","author":"J Oteo","year":"2017","unstructured":"Oteo J, Bou G, Chaves F (2017) Microbiological methods for surveillance of carrier status of multiresistant bacteria. Enferm Infecc Microbiol Clin 35:667\u2013675. https:\/\/doi.org\/10.1016\/j.eimc.2015.12.013","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"5137_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jamcollsurg.2006.06.013","volume":"203","author":"MC Albrecht","year":"2006","unstructured":"Albrecht MC, Griffith ME, Murray CK, Chung KK, Horvath EE, Ward JA et al (2006) Impact of Acinetobacter infection on the mortality of burn patients. J Am Coll Surg 203:546\u2013550. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.06.013","journal-title":"J Am Coll Surg"},{"key":"5137_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2147\/IDR.S163944","volume":"11","author":"A Mart\u00edn-Aspas","year":"2018","unstructured":"Mart\u00edn-Aspas A, Guerrero-S\u00e1nchez FM, Garc\u00eda-Colchero F, Rodr\u00edguez-Roca S, Gir\u00f3n-Gonz\u00e1lez JA (2018) Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist 11:861\u2013872. https:\/\/doi.org\/10.2147\/IDR.S163944","journal-title":"Infect Drug Resist"},{"issue":"4","key":"5137_CR5","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jmii.2023.04.004","volume":"56","author":"HH Kao","year":"2023","unstructured":"Kao HH, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, Chen CM, Shen YC, Zheng ZR, Lin YT, Hsu HS, Feng JY, Yang KY, T-CARE (Taiwan Critical Care and Infection) Group (2023) Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii. J Microbiol Immunol Infect 56(4):822\u2013832 Epub 2023 Apr 27. PMID: 37149411","journal-title":"J Microbiol Immunol Infect"},{"key":"5137_CR6","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00134-005-2598-0","volume":"31","author":"J Garnacho-Montero","year":"2005","unstructured":"Garnacho-Montero J, Ortiz-Leyba C, Fern\u00e1ndez-Hinojosa E, Aldab\u00f3-Pall\u00e1s T, Cayuela A, Marquez-V\u00e1caro JA et al (2005) Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649\u2013655. https:\/\/doi.org\/10.1007\/s00134-005-2598-0","journal-title":"Intensive Care Med"},{"key":"5137_CR7","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s10096-016-2703-z","volume":"36","author":"D Koulenti","year":"2017","unstructured":"Koulenti D, Tsigou E, Rello J (2017) Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study. Eur J Clin Microbiol Infect Dis 36:1999\u20132006. https:\/\/doi.org\/10.1007\/s10096-016-2703-z","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5137_CR8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1086\/667376","volume":"33","author":"KA Thom","year":"2012","unstructured":"Thom KA, Maragakis LL, Richards K, Johnson JK, Roup B, Lawson P et al (2012) Maryland MDRO prevention collaborative. Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. Infect Control Hosp Epidemiol 33:883\u2013888. https:\/\/doi.org\/10.1086\/667376","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5137_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ajic.2020.11.012","volume":"49","author":"AR Smith","year":"2021","unstructured":"Smith AR, Vowles M, Horth RZ, Smith L, Rider L, Wagner JM et al (2021) Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah. Am J Infect Control 49:792\u2013799. https:\/\/doi.org\/10.1016\/j.ajic.2020.11.012","journal-title":"Am J Infect Control"},{"key":"5137_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1017\/ice.2018.52","volume":"39","author":"DL Russell","year":"2018","unstructured":"Russell DL, Uslan DZ, Rubin ZA, Grogan TR, Martin EM (2018) Multidrug resistant Acinetobacter baumanii: A 15-Year trend analysis. Infect Control Hosp Epidemiol 39:608\u2013611. https:\/\/doi.org\/10.1017\/ice.2018.52","journal-title":"Infect Control Hosp Epidemiol"},{"key":"5137_CR11","doi-asserted-by":"publisher","first-page":"e00234","DOI":"10.1128\/CMR.00234-20","volume":"34","author":"CL Holmes","year":"2021","unstructured":"Holmes CL, Anderson MT, Mobley HLT, Bachman MA (2021) Pathogenesis of Gram-Negative bacteremia. Clin Microbiol Rev 34:e00234\u2013e00220. https:\/\/doi.org\/10.1128\/CMR.00234-20","journal-title":"Clin Microbiol Rev"},{"key":"5137_CR12","doi-asserted-by":"publisher","first-page":"107190","DOI":"10.1016\/j.ijantimicag.2024.107190","volume":"64","author":"A Russo","year":"2024","unstructured":"Russo A, Gull\u00ec SP, D\u2019Avino A, Borrazzo C, Carannante N, Dezza FC et al (2024) Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience. Int J Antimicrob Agents 64:107190. https:\/\/doi.org\/10.1016\/j.ijantimicag.2024.107190","journal-title":"Int J Antimicrob Agents"},{"key":"5137_CR13","doi-asserted-by":"publisher","first-page":"dlad085","DOI":"10.1093\/jacamr\/dlad085","volume":"5","author":"E Rando","year":"2023","unstructured":"Rando E, Cutuli SL, Sangiorgi F, Tanzarella ES, Giovannenze F, De Angelis G et al (2023) Cefiderocol-containing regimens for the treatment of carbapenem-resistant A. baumanniiventilator-associated pneumonia: a propensity-weighted cohort study. JAC Antimicrob Resist 5:dlad085. https:\/\/doi.org\/10.1093\/jacamr\/dlad085","journal-title":"JAC Antimicrob Resist"},{"key":"5137_CR14","doi-asserted-by":"publisher","first-page":"106825","DOI":"10.1016\/j.ijantimicag.2023.106825","volume":"62","author":"A Russo","year":"2023","unstructured":"Russo A, Bruni A, Gull\u00ec SP, Borrazzo C, Quirino A, Lionello R et al (2023) Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19. Int J Antimicrob Agents 62:106825. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106825","journal-title":"Int J Antimicrob Agents"},{"key":"5137_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s15010-021-01643-4","volume":"50","author":"A Russo","year":"2022","unstructured":"Russo A, Gavaruzzi F, Ceccarelli G, Borrazzo C, Oliva A, Alessandri F et al (2022) Multidrug-resistant Acinetobacter baumannii infections in COVID-19 patients hospitalized in intensive care unit. Infection 50:83\u201392. https:\/\/doi.org\/10.1007\/s15010-021-01643-4","journal-title":"Infection"},{"key":"5137_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s40121-020-00357-8","volume":"10","author":"A Russo","year":"2021","unstructured":"Russo A, Bassetti M, Bellelli V, Bianchi L, Marincola Cattaneo F, Mazzocchetti S et al (2021) Efficacy of a Fosfomycin-Containing regimen for treatment of severe pneumonia caused by Multidrug-Resistant Acinetobacter baumannii: A prospective, observational study. Infect Dis Ther 10:187\u2013200. https:\/\/doi.org\/10.1007\/s40121-020-00357-8","journal-title":"Infect Dis Ther"},{"key":"5137_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jinf.2019.05.017","volume":"79","author":"A Russo","year":"2019","unstructured":"Russo A, Bassetti M, Ceccarelli G, Carannante N, Losito AR, Bartoletti M, ISGRI-SITA (Italian Study Group on Resistant Infections of the Societ\u00e0 Italiana Terapia Antinfettiva) et al (2019) Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study. J Infect 79:130\u2013138. https:\/\/doi.org\/10.1016\/j.jinf.2019.05.017","journal-title":"J Infect"},{"key":"5137_CR18","doi-asserted-by":"publisher","first-page":"e02562","DOI":"10.1128\/AAC.02562-17","volume":"62","author":"A Russo","year":"2018","unstructured":"Russo A, Giuliano S, Ceccarelli G, Alessandri F, Giordano A, Brunetti G et al (2018) Comparison of septic shock due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in intensive care unit patients. Antimicrob Agents Chemother 62:e02562\u2013e02517. https:\/\/doi.org\/10.1128\/AAC.02562-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5137_CR19","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.2147\/IDR.S319230","volume":"14","author":"Z Zong","year":"2021","unstructured":"Zong Z, Liu H (2021) The impact of colonization by carbapenem-resistant Acinetobacter baumannii in hospital settings: an update. Infect Drug Resist 14:2509\u20132519. https:\/\/doi.org\/10.2147\/IDR.S319230","journal-title":"Infect Drug Resist"},{"issue":"7","key":"5137_CR20","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s10096-022-04620-5","volume":"41","author":"M Paul","year":"2022","unstructured":"Paul M, Tamma PD, Zeng L (2022) Current and future therapeutic options for CRAB infections. Eur J Clin Microbiol Infect Dis 41(7):1233\u20131245. https:\/\/doi.org\/10.1007\/s10096-022-04620-5","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"5137_CR21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/cei.12881","volume":"187","author":"DM Boe","year":"2017","unstructured":"Boe DM, Boule LA, Kovacs EJ (2017) Innate immune responses in the ageing lung. Clin Exp Immunol 187(1):16\u201325. https:\/\/doi.org\/10.1111\/cei.12881","journal-title":"Clin Exp Immunol"},{"key":"5137_CR22","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/cid\/ciad100","volume":"76","author":"M Falcone","year":"2023","unstructured":"Falcone M, Tiseo G, Carbonara S, Marino A, Di Caprio G, Carretta A et al (2023) Advancing knowledge on antimicrobial resistant infections collaboration network (ALARICO network). Mortality Attributable to Bloodstream infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO network). Clin Infect Dis 76:2059\u20132069. https:\/\/doi.org\/10.1093\/cid\/ciad100","journal-title":"Clin Infect Dis"},{"key":"5137_CR23","doi-asserted-by":"publisher","first-page":"1045206","DOI":"10.3389\/fmicb.2022.1045206","volume":"13","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Ding Y, Wei Y, Jian C, Liu J, Zeng Z (2022) Carbapenem-resistant Acinetobacter baumannii: A challenge in the intensive care unit. Front Microbiol 13:1045206. https:\/\/doi.org\/10.3389\/fmicb.2022.1045206","journal-title":"Front Microbiol"},{"issue":"1","key":"5137_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13613-022-00974-3","volume":"26","author":"SI Blot","year":"2022","unstructured":"Blot SI, Koulenti D (2022) Ventilator-associated pneumonia in the ICU: A critical review of mechanisms and management strategies. Crit Care 26(1):101. https:\/\/doi.org\/10.1186\/s13613-022-00974-3","journal-title":"Crit Care"},{"key":"5137_CR25","doi-asserted-by":"publisher","first-page":"e077428","DOI":"10.1136\/bmjopen-2023-077428","volume":"14","author":"ND Stanley","year":"2024","unstructured":"Stanley ND, Jeevan JA, Yadav B, Gunasekaran K, Pichamuthu K, Chandiraseharan VK et al (2024) Association of antibiotic duration and all-cause mortality in a prospective study of patients with ventilator-associated pneumonia in a tertiary-level critical care unit in Southern India. BMJ Open 14:e077428. https:\/\/doi.org\/10.1136\/bmjopen-2023-077428","journal-title":"BMJ Open"},{"key":"5137_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jgar.2021.10.016","volume":"26","author":"M Gajd\u00e1cs","year":"2022","unstructured":"Gajd\u00e1cs M, Buri\u00e1n K (2022) Acinetobacter baumannii: A multidrug-resistant pathogen in hospital-acquired infections. J Global Antimicrob Resist 26:64\u201370. https:\/\/doi.org\/10.1016\/j.jgar.2021.10.016","journal-title":"J Global Antimicrob Resist"},{"key":"5137_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13756-018-0343-z","volume":"7","author":"DHL Ng","year":"2018","unstructured":"Ng DHL, Marimuthu K, Lee JJ, Khong WX, Ng OT, Zhang W et al (2018) Environmental colonization and onward clonal transmission of carbapenem-resistant Acinetobacter baumannii (CRAB) in a medical intensive care unit: the case for environmental hygiene. Antimicrob Resist Infect Control 7:51. https:\/\/doi.org\/10.1186\/s13756-018-0343-z","journal-title":"Antimicrob Resist Infect Control"},{"key":"5137_CR28","doi-asserted-by":"publisher","first-page":"dlad096","DOI":"10.1093\/jacamr\/dlad096","volume":"5","author":"F Cogliati Dezza","year":"2023","unstructured":"Cogliati Dezza F, Covino S, Petrucci F, Sacco F, Viscido A, Gavaruzzi F et al (2023) Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization. JAC Antimicrob Resist 5:dlad096. https:\/\/doi.org\/10.1093\/jacamr\/dlad096","journal-title":"JAC Antimicrob Resist"},{"key":"5137_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCC.0000000000000534","volume":"24","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M (2018) Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant\/extensively drug-resistant\/pandrug-resistant bacteria. Curr Opin Crit Care 24:385\u2013393. https:\/\/doi.org\/10.1097\/MCC.0000000000000534","journal-title":"Curr Opin Crit Care"},{"key":"5137_CR30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/antibiotics13060506","volume":"13","author":"F Serapide","year":"2024","unstructured":"Serapide F, Guastalegname M, Gull\u00ec SP, Lionello R, Bruni A, Garofalo E et al (2024) Antibiotic treatment of Carbapenem-Resistant Acinetobacter baumannii infections in view of the newly developed \u03b2-Lactams: A narrative review of the existing evidence. Antibiot (Basel) 13:506. https:\/\/doi.org\/10.3390\/antibiotics13060506","journal-title":"Antibiot (Basel)"},{"key":"5137_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-024-04936-2","author":"M Peghin","year":"2024","unstructured":"Peghin M, Givone F, de Martino M, Ali RW, Graziano E, Isola M et al (2024) Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization. Eur J Clin Microbiol Infect Dis. https:\/\/doi.org\/10.1007\/s10096-024-04936-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"5137_CR32","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.3390\/jcm11175208","volume":"11","author":"G Montrucchio","year":"2022","unstructured":"Montrucchio G, Corcione S, Lupia T, Shbaklo N, Olivieri C, Poggioli M et al (2022) The burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 patients: A regional experience. J Clin Med 11:5208. https:\/\/doi.org\/10.3390\/jcm11175208","journal-title":"J Clin Med"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05137-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05137-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T12:26:42Z","timestamp":1757161602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05137-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["5137"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05137-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"18 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}